167 related articles for article (PubMed ID: 33203693)
1. Serum IL27 in Relation to Risk of Hepatocellular Carcinoma in Two Nested Case-Control Studies.
Yuan JM; Wang Y; Wang R; Luu HN; Adams-Haduch J; Koh WP; Gao YT; Behari J; Lotze MT
Cancer Epidemiol Biomarkers Prev; 2021 Feb; 30(2):388-395. PubMed ID: 33203693
[TBL] [Abstract][Full Text] [Related]
2. Prediagnostic level of serum retinol in relation to reduced risk of hepatocellular carcinoma.
Yuan JM; Gao YT; Ong CN; Ross RK; Yu MC
J Natl Cancer Inst; 2006 Apr; 98(7):482-90. PubMed ID: 16595784
[TBL] [Abstract][Full Text] [Related]
3. Dietary fatty acids and risk of hepatocellular carcinoma in the Singapore Chinese health study.
Koh WP; Dan YY; Goh GB; Jin A; Wang R; Yuan JM
Liver Int; 2016 Jun; 36(6):893-901. PubMed ID: 26443688
[TBL] [Abstract][Full Text] [Related]
4. Serum interleukin-6 associated with hepatocellular carcinoma risk: a nested case-control study.
Ohishi W; Cologne JB; Fujiwara S; Suzuki G; Hayashi T; Niwa Y; Akahoshi M; Ueda K; Tsuge M; Chayama K
Int J Cancer; 2014 Jan; 134(1):154-63. PubMed ID: 23784949
[TBL] [Abstract][Full Text] [Related]
5. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
[TBL] [Abstract][Full Text] [Related]
6. Prediagnostic levels of serum one-carbon metabolites and risk of hepatocellular carcinoma.
Butler LM; Arning E; Wang R; Bottiglieri T; Govindarajan S; Gao YT; Yuan JM
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1884-93. PubMed ID: 23897582
[TBL] [Abstract][Full Text] [Related]
7. Dose-response association between hepatitis B surface antigen levels and liver cancer risk in Chinese men and women.
Yang Y; Gao J; Li HL; Zheng W; Yang G; Zhang W; Ma X; Tan YT; Rothman N; Gao YT; Chow WH; Shu XO; Xiang YB
Int J Cancer; 2016 Jul; 139(2):355-62. PubMed ID: 26990915
[TBL] [Abstract][Full Text] [Related]
8. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
10. Dichlorodiphenyltrichloroethane and risk of hepatocellular carcinoma.
Persson EC; Graubard BI; Evans AA; London WT; Weber JP; LeBlanc A; Chen G; Lin W; McGlynn KA
Int J Cancer; 2012 Nov; 131(9):2078-84. PubMed ID: 22290210
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of hepatitis B virus surface antigen mutants in Singapore patients with hepatocellular carcinoma and hepatitis B virus carriers negative for HBsAg but positive for anti-HBs and anti-HBc.
Oon CJ; Chen WN; Goh KT; Mesenas S; Ng HS; Chiang G; Tan C; Koh S; Teng SW; Toh I; Moh MC; Goo KS; Tan K; Leong AL; Tan GS
J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S491-6. PubMed ID: 12534784
[TBL] [Abstract][Full Text] [Related]
12. Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma.
Tsai JF; Jeng JE; Ho MS; Chang WY; Hsieh MY; Lin ZY; Tsai JH
Br J Cancer; 1996 Jun; 73(12):1498-502. PubMed ID: 8664119
[TBL] [Abstract][Full Text] [Related]
13. Composite Score of Healthy Lifestyle Factors and Risk of Hepatocellular Carcinoma: Findings from a Prospective Cohort Study.
Luu HN; Behari J; Goh GB; Wang R; Jin A; Thomas CE; Clemente JC; Odegaard AO; Koh WP; Yuan JM
Cancer Epidemiol Biomarkers Prev; 2021 Feb; 30(2):380-387. PubMed ID: 33187965
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD137 and risk of hepatocellular carcinoma: nested case-control studies in cohorts in Shanghai and Singapore.
Thomas CE; Adibi JJ; Kuipers AL; Diergaarde B; Luu HN; Jin A; Koh WP; Gao YT; Adams-Haduch J; Wang R; Lokshin A; Behari J; Yuan JM
Br J Cancer; 2023 Jun; 128(11):2081-2088. PubMed ID: 36977826
[TBL] [Abstract][Full Text] [Related]
15. Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: a prospective study in taiwan.
Chen CL; Yang WS; Yang HI; Chen CF; You SL; Wang LY; Lu SN; Liu CJ; Kao JH; Chen PJ; Chen DS; Chen CJ
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1659-71. PubMed ID: 24895413
[TBL] [Abstract][Full Text] [Related]
16. Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patients.
Mak LY; Ko M; To E; Wong DK; Ma JH; Hui TL; Seto WK; Fung J; Lai CL; Yuen MF
J Gastroenterol Hepatol; 2019 Oct; 34(10):1817-1823. PubMed ID: 30786068
[TBL] [Abstract][Full Text] [Related]
17. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea.
Jee SH; Ohrr H; Sull JW; Samet JM
J Natl Cancer Inst; 2004 Dec; 96(24):1851-6. PubMed ID: 15601641
[TBL] [Abstract][Full Text] [Related]
18. Urinary biomarkers of catechins and risk of hepatocellular carcinoma in the Shanghai Cohort Study.
Butler LM; Huang JY; Wang R; Lee MJ; Yang CS; Gao YT; Yuan JM
Am J Epidemiol; 2015 Mar; 181(6):397-405. PubMed ID: 25713334
[TBL] [Abstract][Full Text] [Related]
19. Association between Hepatitis B Surface Antigen Levels and the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection: Systematic Review and Meta-Analysis.
Thi Vo T; Poovorawan K; Charoen P; Soonthornworasiri N; Nontprasert A; Kittitrakul C; Phumratanaprapin W; Tangkijvanich P
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2239-2246. PubMed ID: 31450890
[TBL] [Abstract][Full Text] [Related]
20. Exposure to bacterial products lipopolysaccharide and flagellin and hepatocellular carcinoma: a nested case-control study.
Fedirko V; Tran HQ; Gewirtz AT; Stepien M; Trichopoulou A; Aleksandrova K; Olsen A; Tjønneland A; Overvad K; Carbonnel F; Boutron-Ruault MC; Severi G; Kühn T; Kaaks R; Boeing H; Bamia C; Lagiou P; Grioni S; Panico S; Palli D; Tumino R; Naccarati A; Peeters PH; Bueno-de-Mesquita HB; Weiderpass E; Castaño JM; Barricarte A; Sánchez MJ; Dorronsoro M; Quirós JR; Agudo A; Sjöberg K; Ohlsson B; Hemmingsson O; Werner M; Bradbury KE; Khaw KT; Wareham N; Tsilidis KK; Aune D; Scalbert A; Romieu I; Riboli E; Jenab M
BMC Med; 2017 Apr; 15(1):72. PubMed ID: 28372583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
